Keywords:
Arteriosclerosis, Diagnostic procedure, CT, Cardiovascular system, Cardiac
Authors:
D. K. Galaska, R. Galaska, J. Fijalkowska, M. Fijalkowski, A. Wegrzyn, E. Szurowska, M. Gruchala; Gdansk/PL
References
1.
Yutzey KE,
Demer LL,
Body SC,
Huggins GS,
Towler D a,
Giachelli CM,
Hofmann-Bowman MA,
Mortlock DP,
Rogers MB,Sadeghi MM,
Aikawa E.:Calcific aortic valve disease: a consensus summary from the alliance of investigators on calcific aortic valve disease.
Arterioscler Thromb Vasc Biol,
2014; 34(11) :2387–93.
2.
Johnson ML,
Rajamannan N: Diseases of Wnt signaling.
Rev Endocr Metab Disord,
2006; 7(1-2): 41–9.
3.
Rajamannan NM,
Subramaniam M,
Caira F,
Stock SR,
Spelsberg TC: Atorvastatin inhibits hypercholesterolemia-induced calcification in the aortic valves via the Lrp5 receptor pathway.
Circulation ,
2005; 112(9 Suppl):I229–34.
4.
Galaska R,
Kulawiak-Galaska D,
Wegrzyn A,
Wasag B,
Chmara M,
Borowiec J,
Studniarek M,
Fijalkowski M,
Rynkiewicz A,
Gruchala M: Assessment of Subclinical Atherosclerosis Using Computed Tomography Calcium Scores in Patients with Familiar and NonFamiliar Hypercholesterolemia.
J Atheroscler Thromb,
2016; 23: 567-587.